
Have you or a loved one experienced liver damage or cancer after taking Veozah (fezolinetant) for menopausal hot flashes? You may be entitled to settlements up to $600,000. The Mass Tort Intake Center connects you with top mass tort attorneys nationwide to fight for your rights. Get a free, no-risk case review now.

You may be entitled to financial compensation.
Your Information is 100% Confidential.
IMPORTANT INFORMATION ABOUT YOUR POTENTIAL CLAIM
*** NO ONE CAN GUARANTEE A SPECIFIC SETTLEMENT AMOUNT OR TIMELINE.***
Veozah, a non-hormonal drug approved by the FDA in May 2023 for menopausal hot flashes, has been linked to severe liver damage and an increased cancer risk. Lawsuits allege that Astellas Pharma failed to warn patients about these dangers, leading to serious injuries. In December 2024, the FDA issued a Boxed Warning after reports of liver injury within 40 days of use, and a December 2024 study found users are 4.3 times more likely to develop cancer.
The Mass Tort Intake Center is here to help you seek justice. Our network of experienced Veozah lawsuit attorneys is investigating claims nationwide, including in California, Texas, and Florida. Contact us today to learn how to file a Veozah liver damage claim and secure the compensation you deserve.

Veozah lawsuits are growing due to:
Inadequate Warnings: Astellas Pharma did not properly disclose the risks of liver damage or cancer.
Negligence: Insufficient safety testing before marketing Veozah to millions of women.
Severe Health Impacts: Patients have suffered liver damage, liver failure, and potential cancer, requiring extensive medical care.
The FDA’s actions, including a September 2024 Drug Safety Communication and the December 2024 Boxed Warning, have sparked increased awareness.
These cases are expected to consolidate into a multidistrict litigation (MDL), which could lead to significant settlements for claimants.